News search

    E.g., 25/01/2025
    E.g., 25/01/2025
    La investigadora Cintia Folgueira
    About the CNIC
    13 Jan 2025
    CNIC research identifies a key protein for ‘burning’ fat

    This work reveals a new mechanism by which brown fat is converted into heat, and which protects from pathologies associated with obesity.
    Macarena de Andrés Laguillo, Stefano Gambera, Sofía Sánchez Muñoz, Rui Benedito, Irene García González, Mariya Lytvyn Legin, Lourdes García Ortega, Sandra Ruiz García, Susana Ferreira da Rocha, Aroa García Cabero, Luis Diago Domingo.
    Research
    12 Dec 2024
    Nature Methods: CNIC presents iFlpMosaics, an innovative genetic toolkit for the study of gene function

    iFlpMosaics is a new technology presented in Nature Methods that allows the modification and study of gene function in mouse models, advancing research on diseases caused by somatic mutations, such as cancer and vascular malformations.
    El Dr. Valentín Fuster recibe el Premio de la Sociedad Internacional de Aterosclerosis
    About the CNIC
    5 Dec 2024
    Valentin Fuster, wins prestigious award from the International Atherosclerosis Society

    The International Atherosclerosis Society recognizes the contributions to the understanding and treatment of atherosclerosis by the director of the National Center for Cardiovascular Research (CNIC) and president of the Mount Sinai Fuster Heart
    Carola Vinuesa
    About the CNIC
    25 Nov 2024
    Carola Vinuesa: "Science offers many opportunities to reinvent yourself, to travel, to work in different environments, and to meet new people"

    Carola García de Vinuesa is a senior group leader at the Francis Crick Institute in London and the John Curtin School of Medical Research in Canberra.

    imagen
    About the CNIC
    23 Oct 2024
    JACARDI General Assembly: More than 200 experts from 21 European countries unite to improve care for cardiovascular disease and diabetes

    The National Center for Cardiovascular Research (CNIC), and the Health Research Institute of Hospital 12 de Octubre (i+12), representing SERMAS, are actively participating in JACARDI through different pilot projects
    Cardiovascular risk factors (particularly metabolic syndrome, insulin resistance, and diabetes) alter coronary microvascular function and increase the risk of atherosclerotic disease, which itself leads to changes in the coronary microcirculation.
    Research
    19 Sep 2024
    JACC: Cardiovascular Imaging: Cardiometabolic risk factors in apparently healthy individuals are linked to altered coronary microcirculation

    A study from CNIC reveals how risk factors and subclinical atherosclerosis affect heart microcirculation in asymptomatic middle-aged individuals. The research, published in JACC: Cardiovascular Imaging, highlights the importance of assessing the heart vessels' ability to regulate blood flow and predict future cardiovascular risk
    image
    Research
    9 Sep 2024
    Circulation: A new mechanism of early-onset atherosclerosis in a premature aging syndrome

    The new study, published in the journal Circulation, opens a new avenue of research into treatments for the atherosclerosis associated with progeria
    team photo
    About the CNIC
    11 Jun 2024
    Nucleic Acids Research: A CNIC team has created an innovative tool for the reliable and efficient study of gene function

    iSuRe-HadCre promises to become an essential tool for biomedical research using mouse models to modify and understand gene function
    Dr. Fuster
    About the CNIC
    17 May 2024
    Dr Valentín Fuster receives the AstraZeneca Foundation Honorific Award for Excellence in Scientific Research
    About the CNIC
    15 May 2024
    CNIC Co-Leads REACT, an international precision medicine project to transform cardiovascular prevention

    Globally, cardiovascular diseases due to atherosclerosis – the build-up of plaque in arteries – are the leading cause of death. A new Danish-Spanish research collaboration aims to develop methods to detect atherosclerosis at earlier ages and encourage prevention. Denmark’s Novo Nordisk Foundation has granted up to EUR 23 million to cover the first 2.5 years of the REACT initiative. The initiative is expected to run for 8 years in total